Bexxar
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
The development of monoclonal antibodies has dramatically changed the outcome of patients with non-Hodgkin’s lymphoma (NHL), the…
The study aimed at identifying patient-specific dosimetric and nondosimetric factors predicting outcome of non-Hodgkin lymphoma…
IntroductionThe American Cancer Society estimated 66,120 new cases of non-Hodgkin lymphoma (NHL) in the USA in 2008…
Currently, beta-emitting radionuclides are used almost exclusively in the clinic and in clinical radioimmunotherapy studies. The…
PURPOSE
Immunotherapy using monoclonal antibodies to specifically target B cells has provided new hope to many patients with…
Tositumomab is an immunoglobulin G murine monoclonal antibody that binds to the CD20 antigen on the surface of normal and…
6518 Background: The sequential combination of chemotherapy and radioimmunotherapy offers a novel strategy for the initial…
Bexxar (131I tositumomab) is a radiolabeled anti-CD20 monoclonal antibody for the treatment of relapsed and refractory follicular…
OBJECTIVE
This article briefly describes the concept of radioimmunotherapy and treatment of non-Hodgkin's lymphoma by a new…